Skip to Content
Stock Analyst Update

Robust Altria Q4 Increases Our Conviction in Valuation

Altria reported another robust performance at the top line in the fourth quarter of 2020. Although we are not changing our $54 fair value estimate, this performance increases our conviction that Altria is undervalued.


Altria (MO) reported another robust performance at the top line in the fourth quarter of 2020. Although we are not changing our $54 fair value estimate, this performance increases our conviction that Altria is undervalued.

Full-year 2020 net revenue grew by 5.3%. This is a rate some other large cap fast-moving consumer goods companies, trading at much higher valuations, can only dream of in the current environment. Even making allowances for what seem likely to be higher channel inventory levels, we estimate revenue grew by almost 4%. Cigarette volumes fell by 0.4% (and by around 3% on an underlying basis, in line with the third quarter), and oral tobacco volumes were also down only very modestly, implying almost 6% price/mix across the portfolio last year. This is a strong performance for two reasons. First, cigarette volumes have been robust in spite of the disruption caused by COVID-19. We believe smokers are consuming more at home than they would if they had been in the office, and this has been confirmed by other commentary and data points by other cigarette manufacturers. While this tailwind may ease after the pandemic is under control, economic stimulus measures in the U.S., which seem likely to continue under the new Democrat-dominated government, have also supported the spending of low-income workers. Second, mid-single-digit price/mix contradicts the notion, misplaced in our view, that the tobacco algorithm is broken. Volumes in 2020 were no doubt supported by consumers switching back to cigarettes from vaping, and Altria estimates the vaping category fell by 10% in 2020. We expect the decline rate to revert to the high end of historical norms of around 3.5%, once that impact is cycled. This should ensure that Altria can grow its top line at a low-single-digit rate in the medium term, and we believe this is not being fairly priced into the company's market value.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Philip Gorham does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.